Join Now

Category Archives: BioUtah News

Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa

By Press Release | Published September 4, 2025

The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa.

| Tagged | Comments Off on Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa

Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor

By Press Release | Published September 4, 2025

Dr. Gordon Ringold to advise on various strategies related to the development of the Company’s novel cancer treatment platform

| Tagged | Comments Off on Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor

BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative

By Press Release | Published September 4, 2025

BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative

| Tagged | Comments Off on BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative

PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy

By Press Release | Published August 28, 2025

Renowned leaders in neurology, movement disorders, and commercialization join to shape Celeste® market strategy

| Tagged | Comments Off on PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

By Press Release | Published August 28, 2025

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.

| Tagged | Comments Off on Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Halia Therapeutics Published in Journey of Drug Targeting

By Press Release | Published August 28, 2025

Halia Therapeutics Published in Journey of Drug Targeting

| Tagged | Comments Off on Halia Therapeutics Published in Journey of Drug Targeting

CancerVax Achieves Major Milestones and Files Foundational Patent Application

By Press Release | Published August 28, 2025

The Company filed a substantial non-provisional PCT patent application seeking worldwide protection for its novel cancer treatment platform

| Tagged | Comments Off on CancerVax Achieves Major Milestones and Files Foundational Patent Application

Epic Ventures Gains $200M Fresh Capital

By Press Release | Published August 28, 2025

Epic Ventures Gains $200M Fresh Capital

| Tagged | Comments Off on Epic Ventures Gains $200M Fresh Capital

Canyon Labs Open House

By Press Release | Published August 28, 2025

Canyon Labs Opens Expanded Facility

| Tagged | Comments Off on Canyon Labs Open House

CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis

By admin | Published August 21, 2025

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability of generic dalfampridine extended release tablets. Dalfampridine is a potassium channel blocker indicated to improve walking in certain adult patients with multiple sclerosis (MS). Specific information about the use of dalfampridine can be found here. CivicaScript will […]

| Comments Off on CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis

HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM

By admin | Published August 21, 2025

The groundbreaking care model expanded from 5 to 15+ clinic locations to achieve 15% patient penetration rate, exceeding national benchmarks SALT LAKE CITY, UT — August 12, 2025 – Huntsman Mental Health Institute at the University of Utah is celebrating the 10th anniversary of its groundbreaking Behavioral Health Integration (BHI) Program, which has transformed mental […]

| Comments Off on HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

By admin | Published August 21, 2025

SALT LAKE CITY, Utah, Aug. 15, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in silicon nitride (Si₃N₄) for medical device applications, today issued a business update in connection with the filing of the Company’s Quarterly Report on Form 10-Q for the period ended June […]

| Comments Off on SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

A Special Thanks To Our Elite Members